The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume II: Technical Report

Paul Grootendorst, Lisa R. Dolovich, Anne M. Holbrook, Adrian R. Levy and Bernie J. O'Brien

Quantitative Studies in Economics and Population Research Reports from McMaster University

Abstract: (see QSEP 369 for abstract)

Keywords: reference pricing; prescription drugs; ACE inhibitors; calcium channel blockers; nitrates; pharmaceutical cost control; seniors; user fees (search for similar items in EconPapers)
JEL-codes: I18 (search for similar items in EconPapers)
Pages: 159 pages
Date: 2002-03
References: Add references at CitEc
Citations:

Downloads: (external link)
http://socserv.mcmaster.ca/qsep/p/qsep370.pdf (application/pdf)
Our link check indicates that this URL is bad, the error code is: 404 Not Found (http://socserv.mcmaster.ca/qsep/p/qsep370.pdf [302 Moved Temporarily]--> https://socialsciences.mcmaster.ca/qsep/p/qsep370.pdf)

Related works:
Working Paper: The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume II: Technical Report (2002)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mcm:qseprr:370

Access Statistics for this paper

More papers in Quantitative Studies in Economics and Population Research Reports from McMaster University Contact information at EDIRC.
Bibliographic data for series maintained by ().